1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cyclosporine in 22 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 30,547 | 3,802 | 6,558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (77.27) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asako, H; Baethge, BA; Granger, DN; Kubes, P; Wolf, RE | 1 |
| Claude, JR; Martin, C; Massicot, F; Pham Huy, C; Thevenin, M; Warnet, JM | 1 |
| Barros, EJ; Boim, MA; Braquet, P; dos Santos, OF; Pirotzky, E; Schor, N | 1 |
| Ortega, G; Parker, L; Shearer, WT; Smith, CS | 1 |
| Conger, JD; Falk, SA; Lanese, DM | 1 |
| Braquet, P; Claude, JR; Dutertre-Catella, H; Martin, C; Massicot, F; Warnet, JM | 1 |
| Boichot, E; Braquet, P; Carré, C; Kyriacopoulos, F; Lagente, V; Mencia-Huerta, JM | 1 |
| Calne, RY; Luddington, R; Metcalfe, SM; St John Collier, DG; Watson, CJ | 1 |
| Bustos, C; Egido, J; Gómez-Guerrero, C; González, E; González-Cuadrado, S; Plaza, JJ; Ruiz-Ortega, M | 1 |
| de Abreu Castro, MS; Dias, MF; Farinelli, P; Ferreira-Alves, DL; Francischi, JN; Kiyomi Funayama Tatsuo, MA; Pacheco, CM; Rocha, OA; Sirois, P | 1 |
| Aupetit, B; Baghos, W; Bagnis, C; Braquet, P; Deray, G; Dubois, M; Jacobs, C; Jacquiaud, C; Pirotzky, E | 1 |
| Foppolo, M; Gallego, MJ; Imberti, B; Micheletti, G; Morigi, M; Remuzzi, A; Remuzzi, G; Zoja, C | 1 |
| Ciccarelli, A; Cirillo, R; de Crescenzo, G; de Paulis, A; Marone, G; Patella, V | 1 |
| Fukata, Y; Naiki, M; Okudaira, H; Suehiro, S; Yamamoto, K; Yanagihara, Y; Yoshii, H | 1 |
| Claude, JR; Godfroid, JJ; Heymans, F; Lamouri, A; Martin, C; Massicot, F; Pham-Huy, C; Warnet, JM | 1 |
| Hawkey, CJ; Stack, WA | 1 |
| Bello-Reuss, E; Ernest, S | 1 |
| Atilla, G; Coker, I; Emingil, G; Hüseyinov, A | 1 |
| Fujimura, A; Kawaguchi, A; Sugimoto, K | 1 |
| Abal, AT; Abul, HT; Haines, DD; Mahmoud, FF; Wise, JA | 1 |
| Ahamed, J; Ali, H; Nuesch, C; Venkatesha, RT; Zaidi, AK | 1 |
| Andréasson, E; Bylund, J; Christenson, K; Dahlgren, C; Forsman, H; Karlsson, A; Önnheim, K | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cyclosporine
| Article | Year |
|---|---|
Specific mediator-directed therapy for gastrointestinal diseases.
Topics: Animals; Antibodies; Cyclosporine; Cytokines; Gastrointestinal Diseases; Humans; Interleukin-1; Interleukin-10; Interleukin-2; Leukotriene Antagonists; Lipoxygenase Inhibitors; Mice; Mice, Knockout; Oligonucleotides, Antisense; Platelet Activating Factor; Prostaglandins; Reactive Oxygen Species; Thromboxanes; Tumor Necrosis Factor-alpha | 1997 |
21 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cyclosporine
| Article | Year |
|---|---|
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules.
Topics: Animals; Capillaries; Cell Adhesion; Cell Movement; Cyclosporine; Leukocytes; Leukotriene B4; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Tacrolimus; Venules | 1992 |
Inhibitory effects of a platelet activating factor-antagonist 48740RP in cyclosporin-induced nephrotoxicity in the rat as assessed by renal glutathione metabolism parameters.
Topics: Aminopeptidases; Animals; Blood Urea Nitrogen; CD13 Antigens; Creatinine; Cyclosporine; Glutathione; Kidney; Kidney Cortex; Platelet Activating Factor; Pyridines; Rats; Thiazoles | 1991 |
Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
Topics: Animals; Blood Pressure; Cyclosporine; Glomerular Filtration Rate; Imidazoles; Kidney; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Thromboxane A2; Thromboxane-A Synthase | 1991 |
Cyclosporin A blocks induction of tumor necrosis factor-alpha in human B lymphocytes.
Topics: B-Lymphocytes; Cell Line; Cyclosporine; Drug Interactions; Gene Expression; Humans; Interleukin-6; Platelet Activating Factor; RNA; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1994 |
Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles.
Topics: Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Endothelin Receptor Antagonists; Endothelins; Fatty Acids, Unsaturated; Furans; Hydrazines; Kidney; Peptides, Cyclic; Platelet Activating Factor; Prostaglandins H; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Protection against cyclosporin-induced nephrotoxicity: 1. Effect of a PAF antagonist, BN50726.
Topics: Animals; Azepines; Creatinine; Cyclosporine; Drug Interactions; Glutathione; Kidney Cortex; Kidney Diseases; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thienopyridines; Urea | 1994 |
Inhibitory effect of cyclosporin A on eosinophil infiltration in the guinea-pig lung induced by antigen, platelet-activating factor and leukotriene B4.
Topics: Animals; Antigens; Betamethasone; Cyclosporine; Eosinophils; Guinea Pigs; Leukotriene B4; Lung; Male; Platelet Activating Factor; Pulmonary Eosinophilia | 1994 |
The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival.
Topics: Animals; Azepines; Cyclosporine; Dogs; Drug Therapy, Combination; Graft Survival; Immunosuppression Therapy; Kidney Transplantation; Platelet Activating Factor; Survival Analysis; Transplantation, Homologous; Triazoles | 1993 |
Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis.
Topics: Animals; Cyclosporine; Female; Immunosuppressive Agents; Inflammation Mediators; Kidney Glomerulus; Nephrosis; Platelet Activating Factor; Proteoglycans; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 1995 |
Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor.
Topics: Animals; Bradykinin; Cyclosporine; Dexamethasone; Dextrans; Diterpenes; Edema; Ginkgolides; Histamine; Immunosuppressive Agents; Inflammation Mediators; Injections, Intravenous; Lactones; Male; Methysergide; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Polyenes; Rats; Serotonin; Serotonin Antagonists; Sirolimus | 1996 |
Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
Topics: Animals; Cyclosporine; Diterpenes; Drug Administration Routes; Ginkgolides; Glomerular Filtration Rate; Hemodynamics; Immunosuppressive Agents; Kidney; Lactones; Male; Perfusion; Plant Extracts; Platelet Activating Factor; Polyethylene Glycols; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasoconstriction | 1996 |
Cyclosporine enhances leukocyte adhesion to vascular endothelium under physiologic flow conditions.
Topics: Cell Adhesion; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; E-Selectin; Endothelium, Vascular; Furans; Humans; Immunosuppressive Agents; In Vitro Techniques; Intercellular Adhesion Molecule-1; Interleukin-1; Leukocytes; Microscopy, Confocal; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 1996 |
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
Topics: Basophils; Binding, Competitive; Bryostatins; Chemokine CCL2; Chemokine CCL5; Complement C5a; Cyclosporine; Histamine Release; Humans; Interleukin-1; Interleukin-8; Kinetics; Lactones; Leukotriene C4; Macrolides; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Platelet Activating Factor; Protein Binding; Tetradecanoylphorbol Acetate | 1996 |
Neurotropin inhibits accumulation of eosinophils induced by allergen through the suppression of sensitized T-cells.
Topics: Adjuvants, Immunologic; Allergens; Animals; Cyclosporine; Eosinophils; Female; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneal Cavity; Platelet Activating Factor; Pollen; Polysaccharides; Rats; T-Lymphocytes | 1995 |
Preventive effects of two PAF-antagonists, PMS 536 and PMS 549, on cyclosporin-induced LLC-PK1 oxidative injury.
Topics: Acetylglucosaminidase; Adenosine Diphosphate; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cyclosporine; Glutathione; Glutathione Peroxidase; Kidney Diseases; LLC-PK1 Cells; Oxidative Stress; Piperazines; Platelet Activating Factor; Platelet Aggregation Inhibitors; Swine | 1997 |
Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Cyclosporine; Glomerular Mesangium; Humans; Platelet Activating Factor; Rhodamine 123 | 1999 |
Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine A.
Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Cyclosporine; Dental Plaque Index; Female; Gingival Crevicular Fluid; Gingival Hemorrhage; Gingival Hyperplasia; Gingival Overgrowth; Gingivitis; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukotriene B4; Male; Periodontium; Platelet Activating Factor; Radioimmunoassay | 2000 |
Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity.
Topics: Animals; Azepines; Cyclosporine; Dose-Response Relationship, Drug; Endothelin-1; Hemodynamics; Immunosuppressive Agents; Kidney; Male; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxane B2; Triazoles | 2001 |
In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects.
Topics: Adult; Asthma; Cells, Cultured; Cyclosporine; Cytokines; Diterpenes; Female; Flow Cytometry; Ginkgolides; Humans; In Vitro Techniques; Interleukin-5; Kuwait; Lactones; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Phytotherapy; Platelet Activating Factor; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2002 |
Platelet-activating factor-induced chemokine gene expression requires NF-kappaB activation and Ca2+/calcineurin signaling pathways. Inhibition by receptor phosphorylation and beta-arrestin recruitment.
Topics: Amino Acid Sequence; Animals; Arrestins; beta-Arrestins; Calcineurin; Calcium; Cell Line; Cell Line, Tumor; Chemokine CCL2; Chemokines; Cyclosporine; Cytoplasm; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Luciferases; Mice; Mice, Knockout; Microscopy, Confocal; Molecular Sequence Data; Mutation; NF-kappa B; NFATC Transcription Factors; Nuclear Proteins; Phosphorylation; Platelet Activating Factor; Protein Structure, Tertiary; Protein Transport; Rats; Signal Transduction; Time Factors; Transcription Factors; Transfection | 2004 |
Reactivation of desensitized formyl peptide receptors by platelet activating factor: a novel receptor cross talk mechanism regulating neutrophil superoxide anion production.
Topics: Actins; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cells, Cultured; Cyclosporine; Cytochalasin B; Cytoskeleton; Gelsolin; Humans; Marine Toxins; NADPH Oxidases; Neutrophils; Oligopeptides; Oxazoles; Peptide Fragments; Platelet Activating Factor; Receptors, Formyl Peptide; Superoxides; Thiazolidines; Triazoles | 2013 |